Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) FCF Margin (2018 - 2025)

Historic FCF Margin for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to 612.3%.

  • Bicycle Therapeutics' FCF Margin rose 8924500.0% to 612.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 4216.68%, marking a year-over-year increase of 75576900.0%. This contributed to the annual value of 13829.92% for FY2024, which is 126307300.0% down from last year.
  • Bicycle Therapeutics' FCF Margin amounted to 612.3% in Q3 2025, which was up 8924500.0% from 2509.73% recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year FCF Margin high stood at 497.32% for Q3 2021, and its period low was 2509.73% during Q2 2025.
  • In the last 5 years, Bicycle Therapeutics' FCF Margin had a median value of 612.3% in 2025 and averaged 598.47%.
  • In the last 5 years, Bicycle Therapeutics' FCF Margin tumbled by -26386500bps in 2021 and then soared by 10596900bps in 2022.
  • Over the past 5 years, Bicycle Therapeutics' FCF Margin (Quarter) stood at 1437.75% in 2021, then soared by 74bps to 378.06% in 2022, then skyrocketed by 177bps to 289.62% in 2023, then crashed by -89bps to 32.15% in 2024, then crashed by -2004bps to 612.3% in 2025.
  • Its last three reported values are 612.3% in Q3 2025, 2509.73% for Q2 2025, and 871.75% during Q1 2025.